Literature DB >> 17093888

Association study of polymorphisms in post-synaptic density protein 95 (PSD-95) with schizophrenia.

S-J Tsai1, C-J Hong, C-Y Cheng, D-L Liao, Y-J Liou.   

Abstract

The postsynaptic density protein 95 (PSD-95) - the prototype of this family - is a modular protein that enables anchoring of NMDA receptors, modulates NMDA receptor sensitivity to glutamate and coordinates NMDA receptor-related intracellular processes. Since hypofunction of NMDA receptors has been implicated in the pathophysiology of schizophrenia, we explored the hypothesis that genetic variants of the PSD-95 gene were associated with a diagnosis of schizophrenia. Three PSD-95 polymorphisms were studied in a sample population of 248 people with schizophrenia and 208 normal controls. One polymorphism (rs373339) was not informative in our Chinese population while the other two polymorphisms (rs2521985 and rs17203281) were analysed with chi-square tests and haplotype analysis. Results demonstrated that the two informative polymorphisms are in strong linkage disequilibrium with each other. Neither single marker nor haplotype analysis revealed an association between variants at the PSD-95 locus and schizophrenia, suggesting that it is unlikely that the PSD-95 polymorphisms investigated play a substantial role in conferring susceptibility to schizophrenia in the Chinese population. Further genetic studies in schizophrenia with other PSD-95-like molecules that interact with the glutamate system are suggested.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17093888     DOI: 10.1007/s00702-006-0587-2

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  15 in total

Review 1.  Ligand-gated ion channel interactions with cytoskeletal and signaling proteins.

Authors:  M Sheng; D T Pak
Journal:  Annu Rev Physiol       Date:  2000       Impact factor: 19.318

2.  Coexpression of postsynaptic density-95 protein with NMDA receptors results in enhanced receptor expression together with a decreased sensitivity to L-glutamate.

Authors:  A R Rutter; F A Stephenson
Journal:  J Neurochem       Date:  2000-12       Impact factor: 5.372

3.  NMDA receptor subunit NRI and postsynaptic protein PSD-95 in hippocampus and orbitofrontal cortex in schizophrenia and mood disorder.

Authors:  Carla Toro; J F W Deakin
Journal:  Schizophr Res       Date:  2005-09-02       Impact factor: 4.939

4.  N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia.

Authors:  S Dracheva; S A Marras; S L Elhakem; F R Kramer; K L Davis; V Haroutunian
Journal:  Am J Psychiatry       Date:  2001-09       Impact factor: 18.112

5.  Serine racemase binds to PICK1: potential relevance to schizophrenia.

Authors:  K Fujii; K Maeda; T Hikida; A K Mustafa; R Balkissoon; J Xia; T Yamada; Y Ozeki; R Kawahara; M Okawa; R L Huganir; H Ujike; S H Snyder; A Sawa
Journal:  Mol Psychiatry       Date:  2006-02       Impact factor: 15.992

Review 6.  Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment.

Authors:  Marc Laruelle; Lawrence S Kegeles; Anissa Abi-Dargham
Journal:  Ann N Y Acad Sci       Date:  2003-11       Impact factor: 5.691

Review 7.  Genes for schizophrenia? Recent findings and their pathophysiological implications.

Authors:  Paul J Harrison; Michael J Owen
Journal:  Lancet       Date:  2003-02-01       Impact factor: 79.321

8.  Neuregulin 1 and susceptibility to schizophrenia.

Authors:  Hreinn Stefansson; Engilbert Sigurdsson; Valgerdur Steinthorsdottir; Soley Bjornsdottir; Thordur Sigmundsson; Shyamali Ghosh; Jon Brynjolfsson; Steinunn Gunnarsdottir; Omar Ivarsson; Thomas T Chou; Omar Hjaltason; Birgitta Birgisdottir; Helgi Jonsson; Vala G Gudnadottir; Elsa Gudmundsdottir; Asgeir Bjornsson; Brynjolfur Ingvarsson; Andres Ingason; Sigmundur Sigfusson; Hronn Hardardottir; Richard P Harvey; Donna Lai; Mingdong Zhou; Daniela Brunner; Vincent Mutel; Acuna Gonzalo; Greg Lemke; Jesus Sainz; Gardar Johannesson; Thorkell Andresson; Daniel Gudbjartsson; Andrei Manolescu; Michael L Frigge; Mark E Gurney; Augustine Kong; Jeffrey R Gulcher; Hannes Petursson; Kari Stefansson
Journal:  Am J Hum Genet       Date:  2002-07-23       Impact factor: 11.025

9.  Altered transcript expression of NMDA receptor-associated postsynaptic proteins in the thalamus of subjects with schizophrenia.

Authors:  Sarah M Clinton; Vahram Haroutunian; Kenneth L Davis; James H Meador-Woodruff
Journal:  Am J Psychiatry       Date:  2003-06       Impact factor: 18.112

10.  Association study of PICK1 rs3952 polymorphism and schizophrenia.

Authors:  Chen-Jee Hong; Ding-Lieh Liao; Hao-Ling Shih; Shih-Jen Tsai
Journal:  Neuroreport       Date:  2004-08-26       Impact factor: 1.837

View more
  6 in total

Review 1.  Calcium-dependent networks in dopamine-glutamate interaction: the role of postsynaptic scaffolding proteins.

Authors:  Andrea de Bartolomeis; Carmine Tomasetti
Journal:  Mol Neurobiol       Date:  2012-07-05       Impact factor: 5.590

2.  Genetic and functional analysis of the DLG4 gene encoding the post-synaptic density protein 95 in schizophrenia.

Authors:  Min-Chih Cheng; Chao-Lin Lu; Sy-Ueng Luu; Ho-Min Tsai; Shih-Hsin Hsu; Tzu-Ting Chen; Chia-Hsiang Chen
Journal:  PLoS One       Date:  2010-12-02       Impact factor: 3.240

3.  Genome-wide Association Study Identifies a Regulatory Variant of RGMA Associated With Opioid Dependence in European Americans.

Authors:  Zhongshan Cheng; Hang Zhou; Richard Sherva; Lindsay A Farrer; Henry R Kranzler; Joel Gelernter
Journal:  Biol Psychiatry       Date:  2018-01-11       Impact factor: 13.382

4.  The glutamatergic aspects of schizophrenia molecular pathophysiology: role of the postsynaptic density, and implications for treatment.

Authors:  Felice Iasevoli; Carmine Tomasetti; Elisabetta F Buonaguro; Andrea de Bartolomeis
Journal:  Curr Neuropharmacol       Date:  2014-05       Impact factor: 7.363

5.  Population-specific haplotype association of the postsynaptic density gene DLG4 with schizophrenia, in family-based association studies.

Authors:  Shabeesh Balan; Kazuo Yamada; Eiji Hattori; Yoshimi Iwayama; Tomoko Toyota; Tetsuo Ohnishi; Motoko Maekawa; Manabu Toyoshima; Yasuhide Iwata; Katsuaki Suzuki; Mitsuru Kikuchi; Takeo Yoshikawa
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

6.  Development of an AmpliSeqTM Panel for Next-Generation Sequencing of a Set of Genetic Predictors of Persisting Pain.

Authors:  Dario Kringel; Mari A Kaunisto; Catharina Lippmann; Eija Kalso; Jörn Lötsch
Journal:  Front Pharmacol       Date:  2018-09-19       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.